CareCam’s First Peer-Reviewed Scientific Paper
Our research highlights how 3DGait can support early detection of functional decline, providing clinicians with objective, scalable tools for improving patient outcomes.
Our research highlights how 3DGait can support early detection of functional decline, providing clinicians with objective, scalable tools for improving patient outcomes.
Key findings include:
– Strong correlation between 3DGait biomarkers and gold-standard lab measurements
– High sensitivity in detecting gait changes associated with early functional decline
– Feasibility of deployment in real-world, non-laboratory settings
We are grateful to our collaborators and the broader research community for their support in bringing this work to light.
This paper is the first of many. Our research pipeline includes studies on Parkinson’s disease, post-stroke rehabilitation, and fall-risk prediction — all powered by 3DGait data.
Next step
Have a question for CareCam?
Technical and clinical questions go to the team who built 3DGait and Vis-Frailty.
Get in touch
